Unlike liquid tumors, we did not find any difference in the expression of MLL1 gene in prostate cancer patients with MLL1 fusions and other prostate cancer patients without MLL1‐fusion (Fig. 2E). The gene discussed is KMT2A; the disease is prostate carcinoma.